Rosuvastatin treatment decreases plasma procoagulant phospholipid activity after a VTE: A randomized controlled trial-Reference-Cited by-同舟云学术

Rosuvastatin treatment decreases plasma procoagulant phospholipid activity after a VTE: A randomized controlled trial

Published:2022-01-08 Issue: Volume: Page:
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J of Thrombosis Haemost

Author:

Ramberg Cathrine¹,Hindberg Kristian¹,Biedermann Joseph S.²³,Cannegieter Suzanne C.⁴⁵^ORCID,van der Meer Felix J.⁴,Snir Omri¹^ORCID,Leebeek Frank W. G.²,Kruip Marieke J. H. A.²³,Hansen John‐Bjarne¹⁶,Lijfering Willem M.⁵^ORCID

Affiliation:

1. Department of Clinical Medicine Thrombosis Research Center (TREC) UiT—The Arctic University of Norway Tromsø Norway

2. Department of Hematology Erasmus MC, Erasmus University Medical Center Rotterdam the Netherlands

3. Star‐shl Anticoagulation Clinic Rotterdam The Netherlands

4. Department of Thrombosis and Haemostasis Leiden University Medical Center Leiden the Netherlands

5. Department of Clinical Epidemiology Leiden University Medical Center Leiden the Netherlands

6. Division of Internal Medicine University Hospital of North Norway Tromsø Norway

Funder

Stiftelsen Kristian Gerhard Jebsen

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15626

Reference53 articles.

1. The epidemiology of venous thromboembolism;White RH;Circulation,2003

2. The epidemiology of venous thromboembolism;Heit JA;J Thromb Thrombolysis,2016

3. Venous thrombosis;Wolberg AS;Nat Rev Dis Primers,2015

4. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report;Kearon C;Chest,2016

5. Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry;Beyer‐Westendorf J;Blood,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of gender differences on the clinical characteristics of critically ill patients with venous thromboembolism: A retrospective, observational study;Medicine;2024-06-14

2. Statins and Hemostasis: Therapeutic Potential Based on Clinical Evidence;Advances in Experimental Medicine and Biology;2023

3. Plasma Phospholipid Fatty Acids and Risk of Venous Thromboembolism: Mendelian Randomization Investigation;Nutrients;2022-08-16

4. Statin therapy in venous thromboembolism: How far from primary and secondary prevention?;Journal of Thrombosis and Haemostasis;2022-08

5. Statins in prevention of thromboembolic events: from seminal studies to recent advances;Polish Archives of Internal Medicine;2022-02-28